AARD News

Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Pomerantz LLP Announces Securities Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

Robbins LLP Urges AARD Stockholders Who Lost Money Investing in Aardvark Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action

AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline

DEADLINE ALERT for HDB, SMPL, AARD, and FTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Pomerantz LLP Commences Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Urged to Join Class Action Before October 13, 2026 - Contact Levi & Korsinsky

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky to Join Class Action Before October 13, 2026